Hays Advisory’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-116,939
| Closed | -$3.92M | – | 80 |
|
|
2016
Q4 | $3.92M | Sell |
116,939
-39,608
| -25% | -$1.33M | 0.87% | 31 |
|
|
2016
Q3 | $4.17M | Sell |
156,547
-16,010
| -9% | -$426K | 0.69% | 35 |
|
|
2016
Q2 | $3.81M | Sell |
172,557
-28,369
| -14% | -$626K | 0.59% | 37 |
|
|
2016
Q1 | $5.9M | Sell |
200,926
-18,172
| -8% | -$534K | 0.83% | 34 |
|
|
2015
Q4 | $7.24M | Sell |
219,098
-28,758
| -12% | -$950K | 1.23% | 32 |
|
|
2015
Q3 | $8.96M | Buy |
+247,856
| New | +$8.96M | 1.35% | 34 |
|